Delcath Systems Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
DCTH Nasdaq 3841 https://delcath.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Delcath Systems Inc

Delcath Systems Provides Business Update and Reports Preliminary First Quarter 2023 Financial Results - May 12th, 2023 12:00 pm
Delcath Systems to Participate in the Lytham Partners Spring 2023 Investor Conference - May 9th, 2023 1:00 pm
Delcath Systems to Host First Quarter 2023 Results - May 3rd, 2023 12:30 pm
Delcath Systems Announces Resumption of Interest-Only Period for Company's Debt Facility - Apr 3rd, 2023 8:30 pm
Delcath Systems Announces Closing of Private Placement of up to $85 Million - Mar 30th, 2023 1:41 am
Why Delcath Systems Shares Are Jumping Today - Mar 27th, 2023 7:15 pm
Delcath Systems Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update - Mar 27th, 2023 12:20 pm
Delcath Systems Announces up to $85 Million Financing - Mar 27th, 2023 12:15 pm
Delcath Systems, Inc. Announces FDA Acceptance of New Drug Application Resubmission of Hepzato Kit with a PDUFA Date of August 14, 2023 - Mar 27th, 2023 12:10 pm
Delcath Announces Rotation of the Board of Directors Chairmanship; John R. Sylvester Appointed New Chairman as Company Prepares for US Commercial Launch - Feb 16th, 2023 1:30 pm
Delcath Systems Announces New Drug Application Resubmission for HEPZATO Kit - Feb 14th, 2023 1:49 pm
Delcath Systems to Participate at the BTIG MedTech, Digital Health, Life Sciences & Diagnostic Tools Conference on February 14 to 16 - Jan 30th, 2023 1:30 pm
Delcath Systems Announces Updated Results from CHOPIN Phase 1b Trial Published in Cardiovascular and Interventional Radiology - Jan 17th, 2023 1:00 pm
Delcath Systems Announces Inducement of Grant Under NASDAQ Listing Rule 5635(C)(4) - Dec 16th, 2022 9:15 pm
Delcath Systems Closes Private Placement of $6.2 Million - Dec 13th, 2022 1:30 pm
Delcath Systems Announces Private Placement of $6.2 Million - Dec 8th, 2022 1:30 pm
Results of a Single Center Study on Delcath's CHEMOSAT® Hepatic Delivery System In the Treatment of Cholangiocarcinoma Published in the Journal Clinical & Experimental Metastasis - Dec 5th, 2022 2:00 pm
Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Nov 9th, 2022 9:15 pm
Delcath Systems Reports Third Quarter 2022 Results and Provides Business Update - Nov 8th, 2022 1:00 pm
Delcath Systems to Host Third Quarter 2022 Results - Oct 24th, 2022 8:05 pm